DEPOSIT SYSTEMS CONTAINING GLATIRAMER ACETATE
CY1126176T1Undetermined Publication Date: 2026-07-31MAPI PHARMA LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CY20231100373T
- Authority / Receiving Office
- CY · CY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2016-08-31
- Filing Date
- 2023-07-28
- Publication Date
- 2026-07-31
- Estimated Expiration
- 2043-07-28
Abstract
The present invention provides compositions and methods of using them for treating or ameliorating multiple sclerosis (MS) by administering a formulation comprising 40 mg of glatiramer acetate intramuscularly to the MS patient.
Need to check novelty before this filing date? Find Prior Art